Journals / Diagnostic and Interventional Radiology / 2019 / Cilt: 25 - Sayı: 6

Effectiveness of the diagnostic pathway of BLES: could it be safely used as a therapeutic method in selected benign lesions?

Pages
428–434
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It may also provide high diagnostic successand even serve as a therapeutic method in high-risk lesions, such as radial scar, papilloma, andatypical lobular hyperplasia with high complete excision rates without fragmentation of lesions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSEIn this study, we aimed to investigate the breast lesion excision system (BLES) as a tool and apractical alternative technique to surgical biopsy and other percutaneous biopsy methods forsuspicious lesions.
📊
Key Findings & Data:We also wanted to share our initial experience with BLES and compare it withstandard percutaneous biopsy methods.METHODSFrom July 2015 to December 2016, a total of 50 patients who had high-risk lesions which werediagnosed with core needle biopsy (CNB) or had lesions with radiology pathology discordance,or had high-risk factors, high-grade anxiety, or suspicious follow-up lesions were enrolled in thestudy.
💡
Conclusion & Impact:It may also provide high diagnostic successand even serve as a therapeutic method in high-risk lesions, such as radial scar, papilloma, andatypical lobular hyperplasia with high complete excision rates without fragmentation of lesions.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Özet

PURPOSEIn this study, we aimed to investigate the breast lesion excision system (BLES) as a tool and apractical alternative technique to surgical biopsy and other percutaneous biopsy methods forsuspicious lesions. We also wanted to share our initial experience with BLES and compare it withstandard percutaneous biopsy methods.METHODSFrom July 2015 to December 2016, a total of 50 patients who had high-risk lesions which werediagnosed with core needle biopsy (CNB) or had lesions with radiology pathology discordance,or had high-risk factors, high-grade anxiety, or suspicious follow-up lesions were enrolled in thestudy. These lesions were classified as Breast Imaging Reporting and Data System (BI-RADS) 3 or 4,which are under 2 cm. Pathologic diagnoses before and after BLES were evaluated comparatively.The diagnostic and therapeutic success and the complications of CNB and BLES were analyzed.RESULTSAfter BLES, two cases were diagnosed as atypical lobular hyperplasia and atypical ductal hyperplasia. Since the surgical margin was negative, re-excision was not required. Two cases werediagnosed as malignant, and no residual tissue was detected in the operation region. Total excision rates were reported as 56%. Minor hematoma was observed in only 1 out of 50 cases(2%), and spontaneous remission was observed. Two patients (4%) complained of pain duringthe procedure. Radiofrequency-related thermal damage to the specimen showed: Grade 0 ( 1.5 mm or thermal damage indiffuse areas) in 2%, and Grade 3 (diffuse thermal damage or inability to diagnose) in 0%. Wefound a significant positive correlation between classification of thermal damage and lesion fatcell content (r = 0.345, P = 0.015).CONCLUSIONBLES is a safe technique that can be effectively used with low complication rates in the excision ofbenign and high-risk breast lesions in selected cases. It may also provide high diagnostic successand even serve as a therapeutic method in high-risk lesions, such as radial scar, papilloma, andatypical lobular hyperplasia with high complete excision rates without fragmentation of lesions.

🔖

Cite This Article

ÖZÇAĞLAYAN, T. İ. K., GÜRDAL, S. Ö., ÖZNUR, M., ÖZÇAĞLAYAN, Ö., DOĞRU, M., TOPÇU, B. (2019). Effectiveness of the diagnostic pathway of BLES: could it be safely used as a therapeutic method in selected benign lesions?. Diagnostic and Interventional Radiology, Cilt: 25 - Sayı: 6, 428–434. https://ajindex.com/articles/349999

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Allen SD, Nerurkar A, Della Rovere, GU. The breast lesion excision system (BLES): a novel technique in the diagnostic and therapeutic management of small indeterminate breast lesions? Eur Radiol 2011
  2. 919–924. [CrossRef ] 2. Hoffmann O, Stamatıs GA, Bittner AK, et al. B3-lesions of the breast and cancer risk analysis of mammography screening patients. Mol Clin Oncol 2016
  3. 705–708. [CrossRef] 3. Blanks R, Wallis M, Jenkins J, Alison R, Wilson RG. An analysis of 11.3 million screening tests examining the association between recall, biopsy and cancer detection rates in the English NHS breast cancer screening programme. Clin Radiol 2019
  4. 384–389. [CrossRef] 4. Parker SH, Lovin JD, Jobe WE, Burke BJ, Hopper KD, Yakes WF. Nonpalpable breast lesions: stereotactic automated large-core biopsies. Radiology 1991
  5. 403–407. [CrossRef] 5. Elvecrog EL, Lechner MC, Nelson MT. Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results. Radiology 1993
  6. 453–455. [CrossRef] 6. Liberman L. Centennial dissertation: percutaneous imaging-guided core breast biopsy-state of the art at the millennium. AJR Am J Roentgenol 2000
  7. 1191–1199. [CrossRef] 7. Gorsuch H, Wilburn-Bailey SJ. Ultrasound-guided, vacuum-assisted, percutaneous excision of breast lesions: an accurate technique in the diagnosis of atypical ductal hyperplasia. J Am Coll Surg 2005
  8. 14–17. [CrossRef] 8. Burbank F, Parker SH, Fogarty TJ. Sterotactic breast biopsy: improved tissue harvesting with Mammatome. Am Surg 1996
  9. 738–744. 9. Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rossen PP. Atypical ductal hyperplasia diagnosed at sterotactic core biopsy of breast lesions: an indication for surgical biopsy. AJR Am J Roentgenol 1995
  10. 1111–1113. [CrossRef] 10. Liberman L, Kaplan JB, Morris EA, Abramson AF, Menell JH, Dershaw DD. To excise or to sample the mamographic target: what is the goal of stereotactic 11-gauge vacuum assisted breast biopsy? AJR Am J Roentgenol 1996
  11. 679– 683. [CrossRef] 11. Citgez B, Atay M, Yetkin GR, Kartal A, Mihmanli M, Uludag M. The breast lesion excision system (BLES) a preliminary experience. Ann Ital Chir 2016
  12. 583–588. 12. Sie A, Bryan DC, Gaines V, et al. Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum-assisted, intact-specimen breast biopsy device. Cancer 2006
  13. 945–949. [CrossRef] 13. Killebrew LK, Oneson RH. Comparison of the diagnostic accuracy of a v